inclusion criteria: 1. signed informed consent, demonstrating that the subject understands the procedures required for the study and the purpose of the study 2. healthy, ambulant male or female subjects 18 years of age to 65 years of age 3. positive test for covid-19 by rt-pcr at screening 4. subjects must agree to practice at least one highly effective method of birth control for the duration of the study. this includes condoms with spermicide, oral birth control pills, contraceptive implants, intra-uterine devices, or diaphragms. subjects not of reproductive potential will be exempt (e.g. post-menopausal, surgically sterilized) 5. subjects must agree they will do their best to attend the treatment facility daily for 10 days

inclusion criteria: 1. signed informed consent, demonstrating that the subject understands the procedures required for the study and the purpose of the study 2. healthy, ambulant male or female subjects 18 years of age to 65 years of age 3. positive test for covid-19 by rt-pcr at screening 4. subjects must agree to practice at least one highly effective method of birth control for the duration of the study. this includes condoms with spermicide, oral birth control pills, contraceptive implants, intra-uterine devices, or diaphragms. subjects not of reproductive potential will be exempt (e.g. post-menopausal, surgically sterilized) 5. subjects must agree they will do their best to attend the treatment facility daily for 10 days

inclusion criteria: signed informed consent, demonstrating that the subject understands the procedures required for the study and the purpose of the study healthy, ambulant male or female subjects 18 years of age to 65 years of age positive test for covid-19 by rt-pcr at screening subjects must agree to practice at least one highly effective method of birth control for the duration of the study. this includes condoms with spermicide, oral birth control pills, contraceptive implants, intra-uterine devices, or diaphragms. subjects not of reproductive potential will be exempt (e.g. post-menopausal, surgically sterilized) subjects must agree they will do their best to attend the treatment facility daily for 10 days

inclusion criteria: signed informed consent, demonstrating that the subject understands the procedures required for the study and the purpose of the study healthy, ambulant male or female subjects 18 years of age to 65 years of age positive test for covid-19 by rt-pcr at screening subjects must agree to practice at least one highly effective method of birth control for the duration of the study. this includes condoms with spermicide, oral birth control pills, contraceptive implants, intra-uterine devices, or diaphragms. subjects not of reproductive potential will be exempt (e.g. post-menopausal, surgically sterilized) subjects must agree they will do their best to attend the treatment facility daily for 10 days

inclusion criteria: 1. signed informed consent, demonstrating that the subject understands the procedures required for the study and the purpose of the study 2. healthy, ambulant male or female subjects 18 years of age to 65 years of age 3. positive test for covid-19 by rt-pcr at screening 4. subjects must agree to practice at least one highly effective method of birth control for the duration of the study. this includes condoms with spermicide, oral birth control pills, contraceptive implants, intra-uterine devices, or diaphragms. subjects not of reproductive potential will be exempt (e.g. post-menopausal, surgically sterilized) 5. subjects must agree they will do their best to attend the treatment facility daily for 10 days

inclusion criteria: 1. signed informed consent, demonstrating that the subject understands the procedures required for the study and the purpose of the study 2. healthy, ambulant male or female subjects 18 years of age to 65 years of age 3. positive test for covid-19 by rt-pcr at screening 4. subjects must agree to practice at least one highly effective method of birth control for the duration of the study. this includes condoms with spermicide, oral birth control pills, contraceptive implants, intra-uterine devices, or diaphragms. subjects not of reproductive potential will be exempt (e.g. post-menopausal, surgically sterilized) 5. subjects must agree they will do their best to attend the treatment facility daily for 10 days